Patricia Osborne
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.
Journal: JAMA
Published: May 14, 2026
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.
Journal: Calcified tissue international
Published: July 05, 2025
Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta.
Journal: BMJ open
Published: November 22, 2023
Patient-reported experience of clinical care of osteogenesis imperfecta (OI) during the COVID-19 pandemic.
Journal: Frontiers in public health
Published: July 19, 2022
Showing 1-4 of 4
Last Updated: 09/26/2026